Related Experiment Video

Updated: Jul 8, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

Effect of statin therapy before Q-wave myocardial infarction on myocardial perfusion

Rainer Hoffmann1, Philipp Haager, Hasna Suliman

  • 1Medical Clinic I, University Hospital RWTH, Aachen, Germany. rhoffmann@ukaachen.de

The American Journal of Cardiology
|January 8, 2008
PubMed

Insights

Statin pretreatment in acute myocardial infarction (AMI) patients reduced systemic inflammation and improved myocardial perfusion after angioplasty. This suggests statins offer benefits beyond lipid lowering in AMI care.

Area of Science:

  • Cardiology
  • Pharmacology
  • Biomedical Science

Background:

  • Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) have known non-lipid-lowering effects.
  • These effects include impacts on endothelial function, inflammation, and platelet activation in stable atherosclerosis.

Purpose of the Study:

  • To evaluate the impact of statin pretreatment on systemic inflammation and myocardial perfusion in acute myocardial infarction (AMI) patients.
  • To assess if statin pretreatment influences outcomes following primary angioplasty.

Main Methods:

  • A prospective study of 253 consecutive patients with AMI undergoing primary angioplasty within 12 hours.
  • Patients were divided into statin pretreatment (n=86) and control (n=167) groups.
  • Myocardial perfusion was assessed using angiographic myocardial blush grade (MBG) post-revascularization.

Main Results:

  • Statin pretreatment was linked to a lower frequency of elevated C-reactive protein on admission (48% vs 64%, p=0.019).
  • A higher frequency of normal myocardial perfusion (MBG 3) was observed in the statin group (45% vs 26%, p<0.001).
  • Statin pretreatment independently predicted normal myocardial perfusion (OR 2.53, p=0.022).

Conclusions:

  • Statin pretreatment in AMI patients is associated with reduced systemic inflammation.
  • Pretreatment with statins correlates with improved myocardial perfusion after primary angioplasty.
  • These findings highlight potential benefits of statins in AMI beyond lipid reduction.

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...